Delivery Order SPE2DR25D2006-SPE2DR26F59DW
Award Date 3/25/26
Potential Completion Date 3/26/26
Potential Value $3.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $43,510.79 delivery order to Amerisourcebergen Drug Corp on March 16, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion March 17, 2026. The order is issued under the parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which enables supply of pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $1,109.19. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside...
- The Defense Logistics Agency issued a $1,856.09 delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion on March 4, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania....
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $8,498.78. The delivery order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion...
- The Defense Logistics Agency issued a $7,764.33 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for Vivitrol 380 mg vial-diluents, with a ceiling value matching the award amount and an ultimate completion date of March 20, 2026. The delivery order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The...
- The Defense Logistics Agency issued a $8,041.80 delivery order to Amerisourcebergen Drug Corp on March 21, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion by March 23, 2026. The order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA.
- The Defense Logistics Agency issued a $14,419.47 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for Vivitrol 380 mg vial-diluents, with an ultimate completion date of March 12, 2026. The order was issued under the DLA Troop Support Medical IDC (SPE2DX), a single-award indefinite delivery contract valued at up to $999,999,999.00 through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of...
- The Defense Logistics Agency issued a $2,817.46 delivery order to AmerisourceBergen Drug Corp on March 19, 2026, for Vivitrol 380 mg vial-diluents, with an ultimate completion date of March 20, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is...
- The Defense Logistics Agency issued a $6,655.14 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for VIVITROL 380 mg vial-diluents, with ultimate completion on March 3, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm fixed price...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $6,021.75. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F59DWDelivery Order
The Defense Logistics Agency issued a $3,327.57 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion on March 26, 2026. Place of performance is Conshohocken, PA. The order was issued under firm fixed-price terms with no set-aside. The source identifies this as a child delivery order against a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling supply of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Generated 6/23/26, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/24/26 |